Ritlecitinib

Litfulo 50 MG Capsulas Duras

80,12 mg cápsula duraSpainMarketedAuthorised 21 Sept 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

LitfuloEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ritlecitinib

Litfulo 50 MG Capsulas Duras

80,12 mg cápsula duraSpainMarketedAuthorised 21 Sept 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

LitfuloEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Litfulo Capsule 50MGSingapore · 50mg · capsule · Pfizer Private Limited

LitfuloUnited States · 50MG BASE · capsule · Pfizer

Packs

Pack	Code	Status
LITFULO 50 MG CAPSULAS DURAS, 30 cápsulas	763337

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ritlecitinib
Strength: 80,12 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 21 Sept 2023
Registration: 1231755002
Marketing authorisation holder: Pfizer Europe Ma Eeig
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/23/1755